Sqad, I'd be the first to agree that aspirin usage in the walking-well remains controversial. Nevertheless, there is currently a growing tide of health professionals who feel that the benefits of aspirin, particularly in the over 50's, outweigh the risks. Peter Rothwell, is one such advocate of preventative aspirin therapy:
http://www.ox.ac.uk/m...ries/2010/101207.html
The data provided in the original Lancet article makes fascinating reading and does not confine itself to the therapeutic benefits of aspirin in the treatment of cancers alone. Elsevier have recently tightened up access to the online version of The Lancet and the URL of the article in my browser is currently showing my .ac identifier. Because of this, I'm afraid I can't post a direct link to the article, but I'm sure you can access it.
Nevertheless, both I and MrsProf agree with you and consider that far more research needs to be conducted in this area. The risk of stomach erosion and bleeding remains an issue that should be at the forefont of the medical practitioners mind prior to prescribing but regretfully, historical evidence tends to indicate the contrary. Incidentally, the general opinion of the researchers is indeed that aspirin should be taken by everybody.
I agree entirely with over aspirin and CVA's. MrsProf tells me that there are an increasing number of documented cases coming to light regarding the matter and she has a colleague who is currently supervising a research group investigating this very issue. Similar studies are currently being undertaken in three other medical schools in the UK right now.
Many studies have been conducted over the years regarding aspirin absorption through the stomach lumen, yet it's known that most absorption occurs in the small and large intesti